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Development of ‘Redox Arrays’ for 
identifying novel glutathionylated 
proteins in the secretome
Lisa Mullen1, Miles Seavill1, Raneem Hammouz1, Barbara Bottazzi2, Philippe Chan3, 
David Vaudry3 & Pietro Ghezzi1
Proteomics techniques for analysing the redox status of individual proteins in complex mixtures 
tend to identify the same proteins due to their high abundance. We describe here an array-based 
technique to identify proteins undergoing glutathionylation and apply it to the secretome and 
the proteome of human monocytic cells. The method is based on incorporation of biotinylated 
glutathione (GSH) into proteins, which can then be identified following binding to a 1000-protein 
antibody array. We thus identify 38 secreted and 55 intracellular glutathionylated proteins, most of 
which are novel candidates for glutathionylation. Two of the proteins identified in these experiments, 
IL-1 sRII and Lyn, were then confirmed to be susceptible to glutathionylation. Comparison of the 
redox array with conventional proteomic methods confirmed that the redox array is much more 
sensitive, and can be performed using more than 100-fold less protein than is required for methods 
based on mass spectrometry. The identification of novel targets of glutathionylation, particularly in 
the secretome where the protein concentration is much lower, shows that redox arrays can overcome 
some of the limitations of established redox proteomics techniques.
Glutathione (GSH) has a key signalling role in redox regulation1–3. A molecular mechanism for the regu-
latory action of GSH is protein glutathionylation, a post-translational modification in which glutathione 
(GSH) forms a disulphide bond with a cysteine of a protein. It is now well accepted that glutathionyla-
tion, which is a reversible process, plays important roles in the redox regulation of protein activity and 
cell signalling4–8.
Key signalling proteins in infection and immunity that can be regulated by glutathionylation include 
p509, STAT310, and HIV protease11. We and others previously showed that protein glutathionylation can 
be regulated by macrophage activators12 and HIV infection13. Interestingly, a number of intracellular 
proteins that can be released and act as endogenous inflammatory signalling molecules (also known as 
‘damage-associated molecular patterns’) can undergo glutathionylation, including high mobility group 
box 1 protein (HMGB-1)14, proteins of the S100 family15, galectin-116, peroxiredoxin-2 (Prdx2)17 and 
heat-shock protein 70 (HSP70)18. Redox proteomics methods for identifying glutathionylated proteins 
have been developed, including labelling of GSH either by 35S16 or biotinylation17,19,20. However, these 
approaches suffer from a common limitation of proteomic methods, where the presence of proteins in 
high-abundance make the identification of ones present in low-abundance very difficult. For this reason, 
abundant proteins such as Prdxs, HSPs, enolase-1 and keratin appear again and again in proteomics 
experiments21. Glutathionylation could potentially affect many biologically important secreted and intra-
cellular proteins that are present in very low concentrations and consequently difficult to identify with 
the usual proteomics technologies22,23. We describe here the development of a ‘redox array’ technology 
which aims to identify glutathionylated proteins irrespective of their relative abundance. The method is 
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based on a similar methodology to that used in our previous study using BioGEE to label the proteins 
undergoing glutathionylation17. The sample is then applied to a commercially available antibody array for 
1000 human proteins and glutathionylated proteins visualized with streptavidin-peroxidase.
Results
Identification of secreted glutathionylated proteins from LPS-treated monocytic cells. 
Human monocytic THP-1 cells were pre-loaded with BioGEE, and then stimulated with lipopolysaccha-
ride (LPS). Cells were treated with LPS as LPS increases protein transcription, translation and secretion, 
thereby increasing the concentration of secreted proteins. LPS also acts as an inflammatory stimulus in 
these cells, a condition which has previously been shown to increase protein glutathionylation and may 
thus enable the identification of novel targets for glutathionylation as part of the inflammatory response. 
After 24 h, supernatants were collected and free BioGEE removed using desalting columns before apply-
ing to a L1000 antibody array. Bound biotinylated proteins were then identified using streptavidin-HRP 
and subsequent detection by ECL (Fig. 1). Antibody spots on the arrays were considered positive if they 
were visible in duplicate. The number of positive spots was determined at an exposure of 5 min for all 
membranes. Longer exposures resulted in increasing the background without increasing the number 
of positive spots. The intensity of the signal was not considered when determining which spots were 
positive, as this could depend on the number of cysteine residues undergoing glutathionylation and 
the absolute amount of the protein. To confirm the specificity of BioGEE labelling of these proteins, a 
second aliquot of the THP-1 supernatant was reduced with DTT to release the BioGEE from the protein 
by reducing the disulphide bond and applied to a second L1000 array (Fig. 2). We could thus identify a 
Figure 1. Schematic representation of the experimental procedure used for the redox arrays. THP-1 
cells were incubated with cell-permeable BioGEE to label the intracellular pool of proteins. After 24 hour 
incubation with LPS to allow secretion of proteins, cell conditioned medium and cell lysates were collected. 
After removal of free BioGEE, proteins were applied to the antibody membrane-based array. Biotin-labelled 
proteins were detected by the addition of streptavidin-HRP, followed by chemiluminescent detection.
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total of 38 potential targets of glutathionylation as a number of proteins, 17 of the 55 detected, were still 
found on the array even after removal of the BioGEE label by DTT treatment. The proteins identified 
are listed in Table 1.
Identification of intracellular glutathionylated proteins in LPS-treated monocytic cells. For 
the analysis of cell lysates, the protein concentration was adjusted to 0.3 mg/mL and applied to the array 
and processed as described above.
To identify false positives, a second aliquot of the sample was treated with DTT as described above. 
A number of proteins, 19 in total, were still detected on the array even after reduction (Table 2) and so 
represent false positives, leaving a total of 55 proteins identified as targets of glutathionylation. A number 
of proteins previously shown to be glutathionylated were also identified here as shown in Table  2. Of 
note, IL-11 has no cysteines but its intracellular precursor has two24, so it is interesting that it was only 
identified intracellularly and not in the secretome. This also suggests that the separation of intracellular 
Figure 2. L1000 antibody arrays (composed of L507 on the left and L493 on the right) identify a 
number of glutathionylated proteins secreted from LPS-treated THP-1 cells. (a) Conditioned media from 
LPS-treated BioGEE-loaded THP-1 cells were applied to the array. Streptavidin-HRP was used to detect 
the presence of bound biotinylated proteins. Triplicate positive control spots are indicated by arrows. (b) A 
second aliquot of the same sample was reduced with DTT and applied to a second array.
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Protein Full name Genbank
Biol. 
Rep 1
Biol 
Rep 
2
Biol 
Rep 
3
Lost 
with 
DDT
4-1BB/TNFRSF91 Tumor necrosis factor receptor superfamily, member 9 NM_001561 ✓ ✓
Aldolase A Aldolase A NM_000034 ✓
ApoD Apolipoprotein D NM_001647 ✓ ✓ ✓
Beta Defensin 4 Beta Defensin 4 NM_004942 ✓ ✓ ✓ ✓
Biglycan Biglycan NM_001711 ✓ ✓ ✓ ✓
BIK B-cell lymphocyte NM_001197 ✓ ✓ ✓
BNIP2 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 NM_004330 ✓ ✓ ✓ ✓
Calbindin Calbindin NM_004929 ✓ ✓ ✓ ✓
CD79 alpha CD79a molecule NM_001783 ✓ ✓ ✓ ✓
Contactin-1* Contactin-1 NM_001843 ✓ ✓ ✓ ✓
Creatinine Creatinine N/A ✓ ✓ ✓
CSH1# Chorionic somatomammotropin hormone 1 NM_001317 ✓ ✓ ✓
CSK Tyrosine-protein kinase CSK NM_004383 ✓ ✓ ✓
Cystatin B* Cystatin B NM_000100 ✓ ✓ ✓ ✓
Endostatin Endostatin; Collagen type 18 contains Endostatin NM_030582 ✓ ✓ ✓
EXTL2*,# Exostosin-like 2 NM_001439 ✓
FABP4 Fatty acid binding protein 4 NM_001442 ✓ ✓ ✓ ✓
FOXN3 Forkhead box N3 NM_005197 ✓ ✓ ✓
FoxO1/FKHR*,# Forkhead box O1 NM_002015 ✓
GDF1 GDF1 (N-term) NM_001492 ✓ ✓ ✓
Ghrelin Ghrelin NM_016362 ✓ ✓ ✓ ✓
Glypican 3 Glypican 3 NM_00484 ✓ ✓ ✓ ✓
HP*,# Haptoglobin NM_005143 ✓ ✓
Hepcidin Hepcidin NM_021175 ✓ ✓ ✓
HSP70 Heat shock protein 70 NM_005345 ✓ ✓ ✓ ✓
ICAM-2 Intercellular Adhesion Molecule 2 NM_000873 ✓ ✓ ✓
L-1 RII* L-1 Receptor II NM_004633 ✓ ✓
L-1 F5/FIL1delta# Human Interleukin 1 family member 5 NM_173170 ✓ ✓
Integrin alpha V# Integrin alpha V NM_002210 ✓ ✓ ✓
Itk# L-2-inducible T cell kinase NM_005546 ✓ ✓ ✓ ✓
ITM2B# Integral membrane protein 2B NM_021999 ✓ ✓ ✓ ✓
LIN41*,# lineage41 NM_001039111 ✓
Livin Livin NM_139317 ✓ ✓ ✓ ✓
NELL2# Neural epidermal growth factor-like 2 NM_006159 ✓ ✓ ✓
Neuropeptide Y# Neuropeptide Y NM_000905 ✓ ✓
NRG2*,# Pro-neuregulin-2, Neuregulin-2, Pro-NRG2 NM_013981 ✓
Omentin/Intelectin Omentin/Intelectin NM_017625.2 ✓ ✓ ✓ ✓
PTHLP*,# Parathyroid Hormone-Like Protein NM_198965 ✓
RELM alpha/RELM beta Resistin-like alpha - Renamed RelmB in humans NM_032579 ✓ ✓ ✓ ✓
S100A10 S100A10, ANX2LG, CAL1L, CLP11 NM_002966 ✓ ✓ ✓ ✓
S100A4 S100 calcium-binding protein A4 NM_002961 ✓ ✓ ✓ ✓
S100A8*,# S100 calcium-binding protein A8 NM_002964 ✓ ✓
SART1*,# Squamous cell carcinoma antigen recognized by T-cells 1 NM_005146 ✓ ✓ ✓
SART3# Squamous cell carcinoma antigen recognized by T-cells 3 NM_014706 ✓ ✓
SRMS# Src-Related Kinase NM_080823 ✓ ✓
TFPI*,# Tissue factor pathway inhibitor NM_006287 ✓ ✓ ✓
Continued
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and secreted proteins was successful, otherwise there would be a positive signal for the IL-11 antibody 
on the array used for detection of glutathionylated secreted proteins.
Identification of glutathionylated proteins in untreated monocytic cells. Finally we performed 
similar experiments in the absence of LPS. The number and identity of secreted glutathionylated proteins 
were very similar, but not identical, between LPS-treated and control cells (Table 3). Cell lysates were also 
prepared from cells without LPS treatment to determine if any proteins were glutathionylated specifically 
in response to LPS. The number and identity of glutathionylated proteins were identical in lysates from 
LPS-treated and unstimulated cells (data not shown).
Validation of novel glutathionylated proteins in THP-1 cells. To validate this method of iden-
tifying glutathionylated proteins, we selected one intracellular protein, Lyn, and one secreted protein, 
IL-1s RII, that had never been shown before to be glutathionylated. To confirm that these proteins were 
susceptible to glutathionylation, we treated the recombinant protein with BioGEE in vitro and analysed 
the extent of BioGEE labelling by Western blot using streptavidin-HRP. Both IL-1 sRII (Fig. 3a) and Lyn 
(Fig.  4a) were heavily labelled with BioGEE and the signal was lost in each case upon treatment with 
DTT, which confirmed the specificity of the signal as due to a mixed disulfide. The identity of each pro-
tein was also confirmed by probing with antibodies specific for IL-1 sRII and Lyn respectively, but due to 
the strength of the streptavidin-HRP signal, this was done on separate membranes where more protein 
was loaded per well for detection with specific antibodies. To confirm that only proteins susceptible to 
glutathionylation were detected using this method, TNF was used as a negative control as it was not 
detected in any of the redox arrays, but does contain 4 cysteines. Recombinant TNF was not labelled with 
BioGEE in the presence of diamide in this in vitro system as shown in supplementary Fig. S1.
Having shown that both IL-1 sRII and Lyn were susceptible to glutathionylation in vitro, we next 
wanted to confirm that these proteins were glutathionylated under physiological cellular conditions. IL-1 
sRII or Lyn was immunoprecipitated from conditioned medium or cell lysates of THP-1 cells that were 
pre-incubated with BioGEE. Biotin labelling of these proteins was demonstrated by Western blotting 
using streptavidin-HRP (Figs  3b and 4b), confirming the glutathionylation of these proteins in THP-1 
cells.
IL-1 sRII was identified in the redox array of the secreted proteins from both unstimulated and 
LPS-treated cells (Tables  1 and 3), but only in one replicate for each experimental condition. Having 
confirmed the glutathionylation of this protein both in vitro and in THP-1 cells, we hypothesized that 
it was not detected in all replicates of the array due to the low concentration present in the cell super-
natants. Such a hypothesis was supported by the fact that IL-1 sRII could not be detected by Western 
blotting without immunoprecipitation (Fig.  3b). Precipitation of protein from THP-1 cell conditioned 
media, followed by Western blotting analysis showed similar amounts of IL-1sRII in the supernatants 
of unstimulated and LPS-treated cells (Fig.  3c), but, again, could only be detected after concentration 
of the protein by acetone precipitation prior to SDS-PAGE and Western blotting. Finally, the absolute 
concentration of IL-1 sRII in the supernatants of THP-1 cells was measured by ELISA. The concentration 
of IL-1 sRII was 30 ± 0.04 pg/mL in the supernatants of both LPS-treated and untreated cells.
Identification of BioGEE labelled proteins by mass spectrometry. The redox arrays were clearly 
very sensitive in detecting biotinylated proteins. However, we wanted to compare the array method to 
more conventional methods of identifying glutathionylated proteins using BioGEE, for example, by mass 
spectrometry following affinity purification on streptavidin beads17,25. To allow a direct comparison to 
Protein Full name Genbank
Biol. 
Rep 1
Biol 
Rep 
2
Biol 
Rep 
3
Lost 
with 
DDT
TGF-beta 5 Transform ing growth factor-beta-5 ✓ ✓ ✓ ✓
Thrombopoietin (TPO)* TSF TPO NM_000460 ✓
TRAIL R3 (TNFRSF10C)* TRAIL R3 (TNFRSF10C) NM_003841 ✓ ✓ ✓
TRPC1* Transient receptor potential cation channel, subfamily C NM_003304 ✓ ✓
TXK# Tyrosine-protein kinase TXK NM_003328 ✓ ✓
Tyk2# Tyrosine kinase 2 NM_003331 ✓ ✓
VDUP-1 Vitamin D3 up-regulated protein 1 NM_006472 ✓ ✓
VEGF-C*,# VEGF-2 is the same as VEGF-C NM_005429 ✓ ✓
Vitamin D Receptor Vitamin D Receptor NM_000376 ✓ ✓ ✓
Table 1.  Secreted proteins identified from 3 biological replicates of LPS-treated THP-1 cells by redox 
array. *indicates proteins identified only in cell supernatants, but not in cell lysates. #indicates proteins 
identified in THP-1 cell supernatants treated with LPS, but not in supernatants from untreated THP-1 cells.
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Protein Full name Genbank
Biol. 
Rep 
1
Biol 
Rep 
2
Lost 
with 
DDT Known 
4-1BB/TNFRSF9 Tumor necrosis factor receptor superfamily, member 9 NM_001561 ✓ ✓ ✓
Activin B* Activin B NM_002193 ✓ ✓
Aldolase A Aldolase A NM_000034 ✓ ✓ ✓
ApoD Apolipoprotein D NM_001647 ✓ ✓ ✓
Beta Defensin 4 Beta Defensin 4 NM_004942 ✓ ✓ ✓
Biglycan Biglycan NM_001711 ✓ ✓
BIK B-cell lymphocyte NM_001197 ✓ ✓
BNIP2 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 NM_004330 ✓ ✓ ✓
Calbindin Calbindin NM_004929 ✓ ✓ ✓
CD79 alpha CD79a molecule NM_001783 ✓ ✓ ✓
CD 163 Cluster of Differntiation 163 NM_203416 ✓ ✓
Complement factor H* Complement factor H NM_000186 ✓
Creatinine Creatinine N/A ✓ ✓
CSH1 Chorionic somatomammotropin hormone 1 NM_001317 ✓ ✓ ✓
CSK Tyrosine-protein kinase CSK NM_004383 ✓ ✓
Cytokeratin 18* Cytokeratin 18 NM_199187 ✓ ✓ ✓
DLL1* Delta-like protein 1 NM_005618 ✓ ✓ ✓
Endostatin Endostatin; Collagen type 18 contains Endostatin NM_030582 ✓ ✓
Endothelin Receptor A Endothelin Receptor A NM_001166055 ✓ ✓
FABP4 Fatty acid binding protein 4 NM_001442 ✓ ✓ ✓ ✓
FOXN3 forkhead box N3 NM_005197 ✓ ✓
Galectin-1* Galectin-1 NM_002305 ✓ ✓ ✓ ✓
GDF1 GDF1 (N-term) NM_001492 ✓ ✓
Ghrelin Ghrelin NM_016362 ✓ ✓ ✓
Glypican 3 Glypican 3 NM_00484 ✓ ✓
HADHA* hydroxyacyl-CoA dehydrogenase NM_000182 ✓ ✓ ✓ ✓
HCR/CRAM-A/B* Human Chemokine Receptor CRAM-A isoform NM_019052 ✓ ✓
Hepcidin Hepcidin NM_021175 ✓ ✓
HSP70 Heat shock protein 70 NM_005345 ✓ ✓ ✓ ✓
ICAM-2 Intercellular Adhesion Molecule 2 NM_000873 ✓ ✓
IL-11* Interleukin 11 NM_000641 ✓ ✓ ✓
IL-1 F5/FIL1delta Human Interleukin 1 family member 5 NM_173170 ✓ ✓ ✓
IL-17R* Interleukin 17 receptor A NM_014339 ✓ ✓
Integrin alpha V Integrin alpha V NM_002210 ✓ ✓ ✓
Itk IL-2-inducible T cell kinase NM_005546 ✓ ✓ ✓
ITM2B Integral membrane protein 2B NM_021999 ✓ ✓ ✓
LBP* Human lipopolysaccharide-binding protein NM 004139 ✓ ✓ ✓
LIF* Leukemia Inhibitory Factor NM_002309 ✓ ✓
LIGHT/TNFSF14* hHomologous to lymphotoxins NM_172014 ✓ ✓
Lep* LEPTIN NM_000230 ✓
Lipocalin-2* Lipocalin 2 NM_005564 ✓ ✓ ✓
Livin Livin NM_139317 ✓ ✓ ✓
Lyn* v-yes-1 Yamaguchi sarcoma viral related oncogene homoloc NM_002350 ✓ ✓ ✓
MCSF/CSF1* Macrophage-colony Stimuating Factor NM_000757 ✓ ✓
NELL2 neural epidermal growth factor-like 2 NM_006159 ✓ ✓ ✓
Continued
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the redox array described here, aliquots of the desalted cell supernatants from THP-1 cells preloaded 
with BioGEE ± LPS were applied to streptavidin agarose using the same volume and concentration of 
desalted supernatant as that applied to the redox arrays. However, no proteins could be visualised by 
Coomassie staining of SDS-PAGE gels, nor were any proteins identified by mass spectrometry (data not 
shown). This was most likely due to the low quantity of proteins recovered from the streptavidin beads. 
Even after concentration of these samples eluted from the streptavidin beads, the mass spectrometry 
profile showed only low intensity peptides and high background noise. These experiments were then 
repeated using 120-fold more input protein for the binding to streptavidin agarose and subsequent elu-
tion and separation by SDS-PAGE. A number of intensely stained bands were observed by Coomassie 
staining of SDS-PAGE gels and a number of proteins were identified by mass spectrometry after tryptic 
digestion of gel bands as shown in Supplementary Table S1. A cut-off of 2 or more unique peptides and 
a score of 20 or higher were used to identify glutathionylated proteins in these experiments. A number 
of proteins are known to bind non-specifically to agarose beads and so tend to be identified in numer-
ous proteomics screening experiments26. Therefore, those proteins that have previously been identified 
as a result of non-specific binding to agarose beads25,26 were removed from the list of identified proteins 
in supplemental Table S1. Only 4 proteins identified by mass spectrometry were present on the array, 
Protein Full name Genbank
Biol. 
Rep 
1
Biol 
Rep 
2
Lost 
with 
DDT Known 
Nesfatin* Nesfatin NM_005013 ✓ ✓ ✓
Neuropeptide Y Neuropeptide Y NM_000905 ✓ ✓ ✓
Omentin/Intelectin Omentin/Intelectin NM_017625.2 ✓ ✓
OPN* Osteopontin NM_000582 ✓ ✓ ✓
p21* cyclin-dependent kinase inhibitor 1A NM_078467 ✓ ✓
Pancreastatin* Pancreastatin NM_001275 ✓ ✓ ✓
PI 16* Peptidase Inhibitor 16 NM_153370 ✓ ✓ ✓
Podocalyxin* Podocalyxin NM_001018111 ✓ ✓ ✓
Prostasin* Prostasin NM_002773 ✓ ✓ ✓
RELMalpha/RELM beta resistin-like alpha - Renamed RelmB in humans NM_032579 ✓ ✓ ✓
S100A10 S100A10, ANX2LG, CAL1L, CLP11 NM_002966 ✓ ✓
S100A4 S100 calcium-binding protein A4 NM_002961 ✓ ✓ ✓ ✓
S-100b* S100 calcium binding protein B NM_006272 ✓ ✓ ✓ ✓
SART3 squamous cell carcinoma antigen recognized by T-cells 3 NM_014706 ✓ ✓ ✓
SCG3* Secretogranin III NM_013243 ✓ ✓ ✓
SLPI antileukoproteinase (abbr.ALP) NM_003064 ✓ ✓
SMAC second mitochondria-derived activator of caspase NM_019887 ✓ ✓
SRMS Src-Related Kinase NM_080823 ✓ ✓ ✓
SSEA-1* Stage-Specific Embryonic Antigen1, CD15 NM_002033 ✓ ✓ ✓
TGF-beta 5 transforming growth factor-beta-5 ✓ ✓
BDCA-3* Thrombomodulin NM_000361 ✓ ✓ ✓
TNFSF3* Lymphotoxin beta NM_009588 ✓ ✓ ✓
TNK1* tyrosine kinase, non-receptor, 1 NM_003985 ✓ ✓
Troponin C* troponin C type 1 NM_003280 ✓ ✓
TXK tyrosine-protein kinase TXK NM_003328 ✓ ✓ ✓
Tyk2 tyrosine kinase 2 NM_003331 ✓ ✓ ✓
uPA* Uurokinase plasminogen activator inducing activity NM_002658 ✓ ✓
VDUP-1 vitamin D3 up-regulated protein 1 NM_006472 ✓ ✓
Vitamin D Receptor Vitamin D Receptor NM_000376 ✓ ✓ ✓
Table 2.  Intracellular proteins identified from two biological replicates of LPS-treated THP-1 cells by 
redox array. *Indicates proteins identified only in cell lysates, but not in cell supernatants.
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Protein Full name Genbank
Biol. 
Rep 1
Biol 
Rep 2
Lost 
with 
DDT
4-1BB/TNFRSF9 Tumor necrosis factor receptor superfamily, member 9 NM_001561 ✓ ✓ ✓
Aldolase A Aldolase A NM_000034 ✓
ApoD/Apolipoprotein D Apolipoprotein D NM_001647 ✓ ✓ ✓
Beta Defensin 4 Beta Defensin 4 NM_004942 ✓ ✓ ✓
Biglycan Biglycan NM_001711 ✓ ✓
BIK B-cell lymphocyte NM_001197 ✓ ✓ ✓
BNIP2 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 NM_004330 ✓ ✓
Calbindin Calbindin NM_004929 ✓ ✓ ✓
CD 163# Cluster of Differntiation 163 NM_203416 ✓ ✓ ✓
CD79 alpha CD79a molecule NM_001783 ✓ ✓ ✓
Contactin-1* Contactin-1 NM_001843 ✓ ✓ ✓
Creatinine Creatinine N/A ✓ ✓
CSK Tyrosine-protein kinase CSK NM_004383 ✓ ✓
Cystatin B* Cystatin B NM_000100 ✓ ✓ ✓
Endostatin Endostatin; Collagen type 18 contains Endostatin NM_030582 ✓ ✓
Endothelin Receptor A# Endothelin Receptor A NM_001166055 ✓
FABP4 Fatty acid binding protein 4 NM_001442 ✓ ✓
FOXN3 Forkhead box N3 NM_005197 ✓ ✓
GDF1 GDF1 (N-term) NM_001492 ✓ ✓
Ghrelin Ghrelin NM_016362 ✓ ✓ ✓
Glypican 3 Glypican 3 NM_00484 ✓ ✓
Hepcidin Hepcidin NM_021175 ✓
HSP70 Heat shock protein 70 NM_005345 ✓ ✓ ✓
ICAM-2 Intercellular Adhesion Molecule 2 NM_000873 ✓ ✓
IL-1 RII* IL-1 Receptor II NM_004633 ✓ ✓
IL-1 R4/ST2*,# IL-1 R4/ST2 NM_016232 ✓ ✓
Livin Livin NM_139317 ✓ ✓ ✓
Omentin/Intelectin Omentin/Intelectin NM_017625.2 ✓ ✓ ✓
RELM alpha/RELM beta Resistin-like alpha - Renamed RelmB in humans NM_032579 ✓ ✓ ✓
ROBO4*,# Human Roundabout homolog 4 NM_019055 ✓ ✓ ✓
S100A10 S100A10, ANX2LG, CAL1L, CLP11 NM_002966 ✓ ✓
S100A4 S100 calcium-binding protein A4 NM_002961 ✓ ✓ ✓
SLPI# Antileukoproteinase (abbr.ALP) NM_003064 ✓ ✓
SMAC# Ssecond mitochondria-derived activator of caspase NM_019887 ✓
TGF-alpha*,# TGF-alpha. ( transformed cell growth factor) NM_003236 ✓
TGF-beta 5 Transforming growth factor-beta-5 ✓ ✓
TRAIL R3 (TNFRSF10C)' TRAIL R3 (TNFRSF10C) NM_003841 ✓ ✓
TRPC1* Transient receptor potential cation channel, subfamily C NM_003304 ✓
VDUP-1 Vitamin D3 up-regulated protein 1 NM_006472 ✓ ✓
Vitamin D Receptor Vitamin D Receptor NM_000376 ✓
Table 3.  Secreted proteins identified from two biological replicates of untreated THP-1 cells by redox 
array. *indicates proteins identified only in cell supernatants, but not in cell lysates. #indicates proteins 
identified in THP-1 cell supernatants treated with LPS, but not in supernatants from untreated THP-1 cells.
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but not identified as glutathionylated in the array experiments described above: complement C3, PEDF, 
thrombospondin and vitamin D binding protein.
Discussion
We describe and validate here a novel method for identifying both intracellular and secreted glutathion-
ylated proteins using a ‘redox array’. A total of 74 and 55, from a total repertoire of 1000, of the antibody 
spots were positive on initial screening using cell lysates or conditioned media respectively. Treatment of 
the proteins with DTT prior to application to the array allowed us to distinguish between those proteins 
where BioGEE had been incorporated into the protein via a non-disulphide mechanism (possibly due to 
interaction with biotin) from those that formed disulphide bonds with the GSH in BioGEE and hence 
were more likely to represent potential targets of glutathionylation. Using this approach 38 secreted and 
55 intracellular potential targets of glutathionylation were identified. Fewer glutathionylated proteins 
were found in the secreted samples, compared to the cell lysates as expected, given the different relative 
amounts of each protein present in these samples. These observations are also in agreement with the 
fact that intracellular proteins normally contain more free cysteines than secreted proteins27, which are 
richer in disulfide bonds. GSH is present mainly intracellularly, which also favours formation of mixed 
disulfides of intracellular proteins.
The importance of repeating the array with the same sample treated with a reducing agent is critical 
to identify false positives. A number of spots were positive even after treating the protein sample with 
DTT so that the signal could not have been due to the presence of the biotin label attached via a disulfide 
bond. Although we considered those as non-specific binding, it should be noted that GSH can bind 
proteins via stable, non-reducible, thioethers, and these could account for some of these positive spots28.
Figure 3. Recombinant IL-1 sRII is glutathionylated in vitro and in THP-1 cells. (a) Western blotting 
of recombinant IL-1 sRII treated with BioGEE in vitro probed with anti-IL-1 sRII antibody (left panel) or 
streptavidin-HRP (right panel). The signal from the streptavidin-labelled protein is lost upon treatment with 
DTT. (b) Immunoprecipitation of IL-1 sRII from cell culture media of untreated THP-1 cells preincubated 
with BioGEE. Biotin labelling of the IL-1 sRII was confirmed by stripping of the membrane and re-probing 
with streptavidin-HRP. (c) Release of IL-1 sRII from THP-1 cells in response to treatment with LPS.
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To further validate this method we confirmed that both Lyn and IL-1sRII are susceptible to glutathio-
nylation in vitro and provide the first evidence that these proteins undergo glutathionylation in THP-1 
cells. Intriguingly, Lyn has previously been identified as a redox sensor that mediates neutrophil recruit-
ment in vivo using a zebrafish larvae model system29. This same study also demonstrated by BIAM label-
ling that Lyn has multiple cysteines that can be oxidized. It appears that Lyn is glutathionylated in THP-1 
cells even in the absence of LPS stimulation, at least on one or more of the 8 cysteine residues present.
Glutathionylated IL-1 sRII was identified in the redox secretome of unstimulated and LPS-treated 
THP-1 cells. We validated the potential for glutathionylation of this protein in vitro and also showed that 
IL-1 sRII is secreted from both unstimulated and LPS-treated THP-1 cells. This is the first evidence, to 
our knowledge, that this protein is glutathionylated and this is most likely because of the very low con-
centration in the secretome which is below the limit of detection for most proteomic methods. The bio-
logical consequences of glutathionylation for both Lyn and IL-1 sRII are currently under investigation.
The fact that few differences were found between the LPS-treated and untreated samples was some-
what surprising, as LPS treatment has previously been shown to increase glutathionylation of a num-
ber of proteins in mouse macrophages25. However, the ability to detect LPS-induced glutathionylated 
proteins by the redox array method is restricted by the number and identity of the antibodies included 
on the array. Of note, none of the 5 previously identified targets of glutathionylation (peroxiredoxin 
1, peroxiredoxin 2, thioredoxin, profilin and vimentin) were present on the antibody array used here. 
Therefore, it may be that the proteins most responsive to glutathionylation in response to LPS were 
simply not present on the array.
Unsurprisingly, many more proteins were identified by mass spectrometry than in the array, given 
that the array was restricted to a total possible pool of 1000 proteins. The fact that the list of proteins 
identified by the redox array was so different from the list identified in the mass spectrometry experi-
ments was intriguing. Indeed, this would indicate that there are significant differences in the detection 
Figure 4. Recombinant Lyn is glutathionylated in vitro and in THP-1 cells. (a) Western blotting of 
recombinant Lyn treated with BioGEE in vitro probed with anti-Lyn antibody (left panel) or streptavidin-
HRP (right panel). The signal from the streptavidin-labelled protein is lost upon treatment with DTT.  
(b) Immunoprecipitation of Lyn from cell lysates of untreated THP-1 cells preincubated with BioGEE. Biotin 
labelling of Lyn was confirmed by stripping of the membrane and re-probing with streptavidin-HRP.
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capabilities of these two methods and this should be considered when deciding on an appropriate meth-
odology for particular biological applications. It is likely that these differences in the two methods arise 
from differences in sensitivity, given that our first mass spec experiment failed to identify any proteins 
when conducted using the same amount of input material as used for the redox arrays. This hypothesis 
is further supported by the fact that we were able to identify glutathionylated IL-1 sRII by redox array 
even when the concentration in cell conditioned media was only 30 pg/mL. The fact that this protein was 
not identified in the mass spectrometry experiments was most likely due to the low relative abundance 
of this protein.
There are two main limitations of the redox array: firstly, a positive signal on the array could also be 
due to a biotinylated protein that binds to the antibody specific ligand thus resulting in a false positive 
signal. Therefore, glutathionylated proteins identified using this method should always be independently 
validated via other methods as shown here for IL-1 sRII and Lyn. Secondly, the protocol is limited by 
the number and identity of antibodies included on the array and so may be more useful for detecting 
glutathionylated proteins under specific experimental conditions where a specific subset of proteins are 
of interest, rather than when a global screening of the entire proteome is required.
Nevertheless, the use of redox arrays could allow a more complete identification of potential tar-
gets of redox regulation (redoxome) than conventional proteomics techniques. In fact, this study sug-
gests that 5% of the cellular proteins are susceptible to glutathionylation, while in previous proteomics 
experiments we never identified more than 40 proteins in the whole proteome16, and less than 50 are 
listed as glutathionylated in the NCBI or UniProt protein databases (http://www.ncbi.nlm.nih.gov/pro-
tein?term= %28glutathionylation%29; http://www.uniprot.org/uniprot/?query= keyword:KW-0318). The 
big advantage of the redox array over more conventional mass spectrometry methods is the much greater 
sensitivity of this technique. This is of particular importance for defining the redox secretome as opposed 
to the proteome, given the much lower concentration of secreted proteins compared to intracellular pro-
teins. The ability to quantify the extent of glutathionylation would represent a substantial improvement 
in this approach, but would require double labelling using two different labels for the protein of interest 
and the BioGEE, and as such poses significant technical challenges.
The application of this technology to the secretome in disease conditions could represent a new 
approach in the identification of biomarkers based on their specific redox state. In fact, in some cases 
the thiol redox state of inflammatory proteins may have better prognostic value than their total protein 
concentration30.
Methods
Reagents. Lipopolysaccharide (LPS) from E. coli 055:B5, menadione, N-Ethylmaleimide (NEM) were 
all purchased from Sigma Aldrich. Recombinant human IL-1 sRII was purchased from R&D systems.
Culture and BioGEE treatment of THP-1 cells. THP-1 cells were routinely cultured in T75 
tissue culture flasks in RPMI (Sigma) supplemented with 10% fetal bovine serum and 100 U/mL 
penicillin-streptomycin. For glutathionylation experiments, 30 × 106 cells were washed with RPMI sup-
plemented with 0.5% FBS and 100 U/mL penicillin-streptomycin and resuspended in a total volume of 
5 mL of the same medium. BioGEE was added to the culture at a final concentration of 250 μ M and 
incubated at 37 °C for 1 h. Cells were then split into two T75 flasks each containing a total volume of 
20 mL of RPMI supplemented with 0.5% FBS and 100 U/mL penicillin-streptomycin and stimulated with 
100 ng/mL of LPS for 24 h. Cells and supernatants were then collected by centrifugation. NEM was added 
to all supernatants and cell lysates to a final concentration of 50 mM immediately after collection.
Redox array protocol. Membrane-based human antibody arrays (Ray Biotech) were used to detect 
glutathionylated proteins. These arrays are Human Antibody Arrays consisting of 1000 antibodies immo-
bilised on nitrocellulose membrane (http://www.raybiotech.com/human-l-1000-array-membrane-2.
html). Free BioGEE was removed from THP-1 cell lysates and supernatants by eluting from a desalting 
PD10 column with PBS. Protein concentration was determined by BCA assay (Pierce) and, in the case 
of cell lysates, adjusted to a concentration of 0.3 mg/mL in blocking buffer (Ray Biotech; proprietary 
buffer) for application to the antibody array. Cell supernatants were applied to the array without further 
dilution. After washing, biotinylated proteins were detected according to the manufacturer’s instructions 
(Ray Biotech) using Streptavidin-HRP and ECL reagent.
Cloning of human Lyn in pcDNA6. The sequence coding for human Lyn was amplified by PCR 
from a cDNA clone (MGC; GE Healthcare). The primers used also introduced restriction sites for BamHI 
and XhoI as follows sense: ctag GGATCC ATG GGA TGT ATA AAA TCA AAA GGG and anti-sense: 
5′ ctag CTC GAG GC AGG CTG CTG CTG GTA TTG CCC TTC 3′ . The resulting fragment was 
digested with BamHI and XhoI and ligated into pcDNA6 (Invitrogen) also digested with BamHI and 
XhoI. The sequence of the construct was verified by sequencing.
Culture and transient transfection of 293T cells. 293T cells were routinely cultured in DMEM 
(Sigma) supplemented with 10% fetal bovine serum and penicillin and streptomycin. Transient transfec-
tions were performed using 25 kDa linear polyethylenimine (PEI) (purchased from Polysciences Inc. PA, 
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USA). Stock solutions of PEI were prepared in water at a concentration of 1 mg/ml, and the pH adjusted 
to 7.0. The transfection conditions used are essentially those as previously described31. Briefly, HEK 293T 
cells were plated at a density of 0.5 × 106 cells/well in 6-well plates and transfected with 5 μ g of DNA. The 
transfection complex was formed at a DNA:PEI ratio of 1:3 in OPTI-MEM (Life Technologies, Paisley, 
UK), with a 30 minute incubation at room temperature prior to addition to the cells. 24 h later, culture 
media were replaced with 1 mL of serum-free DMEM containing 50 ng/mL of recombinant hTNF-α 
(Peprotech) and cultured for a further 24 h before collecting cells and supernatants. NEM was added to 
cell lysates to a final concentration of 50 mM immediately after collection to prevent post-lysis glutathio-
nylation by blocking free thiols in both proteins and BioGEE, and also prevent thiol-disulfide exchange 
reactions that could result in loss of glutathionylation.
Purification of recombinant Lyn. 293T cells expressing recombinant His-tagged Lyn were lysed in 
cold NP-40 lysis buffer and incubated on ice for 30 min. Cleared supernatants were loaded onto HisTrap 
columns and allowed to enter the resin by gravity flow. The column was washed with 10 mL of binding 
buffer, followed by 10 mL of wash buffer, before eluting the bound proteins using 3 mL of elution buffer.
Cell-free glutathionylation experiments. Fifty ng of recombinant IL-1sRII (R&D systems) or 
recombinant Lyn purified from HEK293T cells were treated with 100 mM of DTT for 20 min at room 
temperature to reduce free cysteines. DTT was then removed from the sample on a NAP5 desalting 
column (GE Healthcare). BioGEE was added to a final concentration of 250 μ M and incubated at room 
temperature for 15 min, followed by the addition of 0.5 mM diamide and a further 15 min incubation 
at room temperature. The reaction was terminated by the addition of NEM to a final concentration of 
50 mM. Free BioGEE was removed by desalting using a NAP5 column as described above. A portion of 
the sample was reduced with 100 mM DTT (final concentration) to remove the BioGEE label.
Western blot analysis and immunoprecipitation. Proteins from the cell conditioned media of 
THP-1 cells were precipitated by the addition of 3 volumes of ice-cold acetone, incubation at − 20 °C for 
18 hours, and centrifugation at 13,000 × g for 10 min at 4 °C. Protein pellets were solubilized in Laemmli 
buffer and subjected to Western blot analysis as detailed below. 293T cell culture supernatants were 
applied to 12% SDS-PAGE gels without prior dilution and transferred to nitrocellulose membranes 
(Millipore, Watford, UK) by electroblotting at 400 mA, 1.5 h, 4 °C. After blocking in 5% skimmed milk 
in PBS containing 0.05% Tween 20, membranes were probed with anti-human Lyn monoclonal mouse 
antibody (Santa Cruz) diluted 1:1000, or anti-human IL-1 sRII mouse antibody, Clone 8.532 followed by 
detection with anti-mouse-IgG-horseradish peroxidase conjugate diluted at 1:5000 in blocking buffer 
(Stratagene). In some experiments, glutathionylated proteins were detected by probing membranes with 
streptavidin-HRP diluted 1:25,000 in 1% BSA. Blots were developed using advanced chemiluminescence 
(ECL) reagents (GE Healthcare, Amersham, UK) and exposed to autoradiography using Hyperfilm (GE 
Healthcare). Films were developed using an AGFA Curix 60 developer (Agfa Healthcare, Middlesex, 
UK). For immunoprecipitations (IP), 5 μ g of the corresponding Ab were added to 1.5 mL of cell lysate 
or 10 mL of cell conditioned media and incubated at 4°C for 18 h on a rotator. One hundred microliters 
of a 50% slurry of prewashed protein G-agarose beads (GE Healthcare) was then added to each sample, 
followed by incubation for an additional 4 h at 4°C. The samples were washed four times in PBST, solu-
bilized in Laemmli buffer, and subjected to Western blot analyses as described above.
ELISA. The concentration of IL-1 sRII was determined in cell supernatants using a commercially avail-
able ELISA (R&D systems).
Mass Spectrometry. For the identification of secreted glutathionylated proteins, desalted superna-
tants were incubated with 200 μ L of streptavidin beads (streptavidin immobilized on agarose CL-4B; 
Sigma-Aldrich), after which the beads were washed first with PBS and then with NH4CO3. The beads 
were then subjected to tryptic digestion, performed with 5 μ L of 25 ng/mL trypsin and 45 μ L of 25 mM 
NH4 HCO3 on ice for 45 min, incubated overnight at 37 °C. The resulting tryptic peptides were extracted 
by 5% formic acid/50% acetonitrile and concentrated using a SpeedVac (Thermo Scientific).
In a second set of experiments, supernatants from three experiments were pooled and concentrated 
120-fold before applying to 500 μ L of streptavidin agarose. After extensive washing with PBS and then 
NH4CO3, bound proteins were eluted with 100 mM DTT, concentrated 5-fold and applied to 12% 
SDS-PAGE gels. The resulting gel bands were excised and subjected to trypsin in-gel digestion essentially 
as previously described33.
After digestion, peptides were dried on SpeedVac, resuspended in 25 μ L of 3% (v/v) acetonitrile and 
0.1% (v/v) formic acid and then analyzed with a nano-LC1200 system coupled to a Q-TOF 6550 mass 
spectrometer equipped with a nanospray source and an HPLC-chip cube interface (Agilent Technologies). 
A 34-min linear gradient (3–75% acetonitrile in 0.1% formic acid), at a flow rate of 350 nL/min, was 
used to separate peptides on polaris-HR-Chip C18 column (150 mm long × 75 μ m inner diameter). Full 
autoMS1 scans from 290 to 1700 m/z and autoMS2 from 59 to 1700 m/z were recorded. In every cycle, 
a maximum of 8 precursors sorted by charge state (2+ preferred and single-charged ions excluded) 
were isolated and fragmented in the collision cell that was automatically adjusted depending on the m/z. 
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Active exclusion of these precursors was enabled after 1 spectrum within 1 min, and the absolute thresh-
old for precursor selection was set to 1000 counts (relative threshold 0.001%). For protein identification, 
MS/MS peak lists were extracted (merge MSn scans with the same precursor at + /− 30 s retention time 
and + /− 0.05 m/z tolerance) and compared with the protein databases by using the Spectrum Mill MS 
proteomics workbench (Agilent Technologies, Rev B.04.00.127). The searches were performed with the 
following specific parameters: enzyme specificity, trypsin; two missed cleavages permitted; no fixed mod-
ifications; variable modifications, methionine oxidation, cysteine carbamidomethylation, pyroglutamic 
acid (N-termQ); monoisotopic; peptide charge, 2+ and 3+ ; mass tolerance for precursor ions, 20 ppm; 
mass tolerance for fragment ions, 50 ppm; ESI-QUAD-TOF as instrument; taxonomy, Human; database, 
UniProtKB/Swiss-Prot release 2012_11. Only significant hits with a false discovery rate (FDR = 1%) for 
peptides and proteins were considered.
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